help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
A more recent version of this article appeared on July 1, 2007

Published online before print May 18, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ajpath.2007.070135v1
171/1/2    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erwig, L.-P.
Right arrow Articles by Henson, P. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Erwig, L.-P.
Right arrow Articles by Henson, P. M.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.070135

Accepted for publication April 17, 2007.

Article

Immunological Consequences of Apoptotic Cell Phagocytosis

Lars-Peter Erwig*{dagger}@ and Peter M. Henson{dagger}

From the Department of Medicine and Therapeutics,* Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom; and the Program in Cell Biology,{dagger} Department of Paediatrics, National Jewish Medical and Research Center, Denver, Colorado

@ To whom correspondence should be addressed. E-mail: mmd288{at}abdn.ac.uk.


  Abstract

Cells undergo apoptosis in development, tissue homeostasis, and disease and are subsequently cleared by professional and nonprofessional phagocytes. There is now overwhelming evidence that phagocyte function is profoundly altered following apoptotic cell uptake, with consequences for the ensuing innate and adaptive immune response. Pathogens and tumors exploit the changes in macrophage function following apoptotic cell uptake. Here, we will outline the consequences of apoptotic cell phagocytosis and illustrate how apoptotic cells could be used to manipulate the immune response for therapeutic gain.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. M. Behrens, Y. Ning, N. Muvarak, P. W. Zoltick, A. W. Flake, and S. Gallucci
Apoptotic Cell-Mediated Immunoregulation of Dendritic Cells Does Not Require iC3b Opsonization
J. Immunol., September 1, 2008; 181(5): 3018 - 3026.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. D. Behrens, W. M. Wagner, C. J. Krco, C. L. Erskine, K. R. Kalli, J. Krempski, E. A. Gad, M. L. Disis, and K. L. Knutson
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity
Blood, February 1, 2008; 111(3): 1472 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Eken, O. Gasser, G. Zenhaeusern, I. Oehri, C. Hess, and J. A. Schifferli
Polymorphonuclear Neutrophil-Derived Ectosomes Interfere with the Maturation of Monocyte-Derived Dendritic Cells
J. Immunol., January 15, 2008; 180(2): 817 - 824.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.